First Affiliated Hospital Xi'an Jiaotong University
Clinical trials sponsored by First Affiliated Hospital Xi'an Jiaotong University, explained in plain language.
-
Oral arsenic formula could save lives in critical first days of leukemia
Disease control Recruiting nowThis study tests whether adding an oral arsenic-based medicine (RIF) to standard treatment right away can reduce early deaths in patients with acute promyelocytic leukemia (APL), a fast-moving blood cancer. The trial will enroll 224 adults newly suspected of having APL and random…
Phase: PHASE3 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Can plugging a tiny heart hole stop migraines?
Disease control Recruiting nowThis study is testing if closing a common, small hole in the heart (called a PFO) can reduce migraine headaches. Researchers will compare migraine symptoms and brain scans in adults with migraines before and after the closure procedure. The goal is to see if this treatment helps …
Phase: NA • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope to block Statin's sneaky side effect
Prevention Recruiting nowThis study is testing if a drug called Ursodeoxycholic acid (UDCA) can prevent a common side effect of cholesterol-lowering statins: rising blood sugar levels. Researchers will enroll 128 adults with high cholesterol who are starting statin therapy. Participants will take either …
Phase: NA • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Prevention
Last updated Apr 01, 2026 14:41 UTC
-
Safer shield for transplant patients? new drug aims to block dangerous virus
Prevention Recruiting nowThis study is testing a new drug called leymovir to prevent cytomegalovirus (CMV) infection in people who have recently received a kidney transplant. It will compare leymovir to the current standard drug, valganciclovir, in 290 Chinese patients to see if it works as well and is s…
Phase: PHASE4 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Prevention
Last updated Mar 16, 2026 15:24 UTC